Psychosocial implications of Thalassemia Major

Pediatrics International

Volumn 47, Issue 1, 2005, Pages 84-89

  Aydinok, Yesim ^a   Erermis, Serpil ^a   Bukusoglu, Nagihan ^a   Yilmazi, Deniz ^a   Solak, Ufuk ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Compliance; Desferrioxamine; Psychosocial; Thalassemia Major

Indexed keywords

DEFEROXAMINE MESYLATE; FERRITIN;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CAUSE OF DEATH; CHILD; CHILD BEHAVIOR; CHILD BEHAVIOR CHECKLIST; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENURESIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MORBIDITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; SCORING SYSTEM; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; THALASSEMIA MAJOR; TIC;

BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD BEHAVIOR; COST OF ILLNESS; DEFEROXAMINE; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; IRON CHELATING AGENTS; MALE; MOTHERS; PATIENT COMPLIANCE; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL;

EID: 14644407445     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2004.02009.x     Document Type: Article

References (17)

1. Olivieri NF, Brittenham GM. Iron chelating therapy and the treatment of thalassemia. Blood 1997; 89: 739-61.
2. Brittenham GM, Griffith PM, Nienhuis AW. Efficacy of desferrioxamine in preventing complications of iron overload in patients with thalassemia major. N. Engl. J. Med. 1994; 331: 567-73.
3. Olivieri NF, Nathan DG, MacMillan JH. Survival in medically treated patients with homozygous β thalassemia. N. Engl. J. Med. 1994; 331: 574-8.
4. Gabutti V, Piga A. Results of long-term iron chelation therapy. Acta Haematol. 1996; 95: 26-36.
5. Borgna-Pignatti C, Rugoltto S, De-Stafano P et al. Survival and disease complications in thalassemia major. Ann. NY Acad. Sci. 1998; 850: 227-31.
6. Erol N, Aslan L, Akçakin M. The adaptation and standardisation of the child behaviour checklist among 6-18 year-old Turkish children. In: Sergeant J (ed). Eunethydis European Approaches to Hyperkinetic Disorders. Fotorotor Egg, Zurich, 1995; 109-13.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press, Washington DC, 1994; 165-74.
8. Derogatis LR. SCL-90, Administration, Scoring and Procedures Manual-I, 2nd edn. John Hopkins University, School of Medicine, USA, 1977.
9. Olivieri NF. The β-thalassemias. N. Engl. J. Med. 1999; 341: 99-109.
10. Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann. NY Acad. Sci. 1998; 850: 191-201.
11. Kattamis A, Dinopoulos A, Ladis V, Berdousi H, Kattamis C. Variations of ferritin levels over a period of 15 years as a compliance chelation index in thalassemic patients. Am. J. Hematol. 2001; 68: 221-4.
12. Treadwell MJ, Weissman L. Improving adherence with desferrioxamine regimens for patients receiving chronic transfusion therapy. Semin. Hematol. 2001; 38: 77-84.
13. Johnson SB, Pollak T, Silverstein J et al. Cognitive and behavioral knowledge about insulin dependent diabetes among children and parents. Pediatrics 1982; 69: 708-13.
14. Tsiantis J, Dragonas T, Richardson C, Anastasopoulos D, Masera G, Spinetta J. Psychosocial problems and adjustment of children with beta-thalassemia and their families. Eur. Child Adolesc. Psychiatry 1996; 5: 193-203.
15. Weller EB, Weller RA, Swadjian H, Lewis M (ed). Mood disorders In: Lewis M (ed) Child and Adolescent Psychiatry, 2nd edn. Williams & Willikins Company, Baltimore, 1996; 650-65.
16. Reid GJ, Dubow EF, Carey TC. Contribution of coping to medical adjustment and treatment responsibility among children and adolescents with diabetes. J. Dev. Behav. Pediatr. 1994; 15: 327-35.
17. Beratis S. Psychosocial status in pre-adolescent children with beta-thalassemia. J. Psychosom. Res. 1993; 37: 271-9.